| 1 |
Deuterium in Drug Discovery and Development
Scott L. Harbeson, Roger D. Tung · Annual reports in medicinal chemistry
Book chapter |
2011 |
145 |
| 2 |
Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders
Gabriëlla A.M. Blokland et al. · Biological Psychiatry
Open access961 authors |
23 Mar 2021 |
142 |
| 3 |
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study
Natasha Atanaskova Mesinkovska, Brett King, Paradi Mirmirani et al. · Journal of Investigative Dermatology Symposium Proceedings
Conference paperOpen access |
21 Oct 2020 |
110 |
| 4 |
Deuterium Medicinal Chemistry Comes of Age
Roger D. Tung · Future Medicinal Chemistry
Open access |
Apr 2016 |
98 |
| 5 |
Development of the alopecia areata scale for clinical use: Results of an academic–industry collaborative effort
Brett King et al. · Journal of the American Academy of Dermatology
Open access |
30 Aug 2021 |
90 |
| 6 |
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata
Brett King, Natasha Atanaskova Mesinkovska, Paradi Mirmirani et al. · Journal of the American Academy of Dermatology
Open access |
29 Mar 2022 |
85 |
| 7 |
Altering Metabolic Profiles of Drugs by Precision Deuteration 2: Discovery of a Deuterated Analog of Ivacaftor with Differentiated Pharmacokinetics for Clinical Development
Scott L. Harbeson, Adam J. Morgan, Julie F. Liu et al. · Journal of Pharmacology and Experimental Therapeutics
Open access |
13 Jun 2017 |
85 |
| 8 |
Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets
Anton Bespalov, Thomas Steckler, Bruce M. Altevogt et al. · Nature Reviews Drug Discovery
Open access |
17 Jun 2016 |
85 |
| 9 |
Clinical Genetics Lacks Standard Definitions and Protocols for the Collection and Use of Diversity Measures
Alice B. Popejoy, Kristy Crooks, Stephanie Malia Fullerton et al. · The American Journal of Human Genetics
Open access |
5 Jun 2020 |
81 |
| 10 |
Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects
Jean‐Francois Marier, Martin Béliveau, Samer Mouksassi et al. · The Journal of Clinical Pharmacology
|
30 Oct 2008 |
78 |
| 11 |
Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form
Fang‐Ju Lin, Alan Simon Pickard, Jerry A. Krishnan et al. · BMC Medical Research Methodology
Open access |
16 Jun 2014 |
74 |
| 12 |
The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Donna R. R Rivera et al. · Clinical Pharmacology & Therapeutics
Open access |
20 Oct 2021 |
59 |
| 13 |
Altering Metabolic Profiles of Drugs by Precision Deuteration: Reducing Mechanism-Based Inhibition of CYP2D6 by Paroxetine
Vinita Uttamsingh, Richard Gallegos, Julie F. Liu et al. · Journal of Pharmacology and Experimental Therapeutics
|
6 May 2015 |
59 |
| 14 |
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
Xin Yang Hu, Mark Stephen Walker, Edward J. Stepanski et al. · JAMA Network Open
Open access |
10 Aug 2022 |
50 |
| 15 |
Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib
Joanna K Towles, Rebecca N Clark, Michelle D. Wahlin et al. · Drug Metabolism and Disposition
Open access |
23 Jul 2016 |
45 |
| 16 |
A Decade of Deuteration in Medicinal Chemistry
Julie F. Liu, Scott L. Harbeson, Christopher L. Brummel et al. · Annual reports in medicinal chemistry
Book chapter |
2017 |
39 |
| 17 |
OnabotulinumtoxinA Injection for Poststroke Upper‐Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process
David Martin Simpson, Atul T. Patel, Abraham Alfaro et al. · PM&R
Open access |
23 Jun 2016 |
39 |
| 18 |
Enhancing e-communities with agent-based systems
S Case, Nader Azarmi, Marcus Thint et al. · Computer
|
Jul 2001 |
39 |
| 19 |
Clinical Pathway for Suicide Risk Screening in Adult Primary Care Settings: Special Recommendations
Lynsay A. Ayer, Lisa M. Horowitz, Lisa J. Colpe et al. · Journal of the Academy of Consultation-Liaison Psychiatry
Open access |
23 May 2022 |
37 |
| 20 |
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data
Hans Rollema, Raymond S Hurst · Psychopharmacology
|
6 Jul 2018 |
37 |
| 21 |
Deuterium Medicinal Chemistry: A New Approach to Drug Discovery and Development
Scott L. Harbeson, Roger D. Tung
|
May 2014 |
32 |
| 22 |
The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States
Adesuwa S. Ogbomo, Yuen Tsang, Rajesh Mallampati et al. · Journal of Managed Care & Specialty Pharmacy
Open access |
Jun 2022 |
31 |
| 23 |
A First‐in‐Patient, Multicenter, Double‐Blind, 2‐Arm, Placebo‐Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP‐499, in Chronic Kidney Disease
LuAnn Sabounjian, Philip B. Graham, Lijun Wu et al. · Clinical Pharmacology in Drug Development
Open access |
Dec 2015 |
27 |
| 24 |
Real‐world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot
Laura Lasiter, Olga Tymejczyk, Elizabeth S. Garrett-Mayer et al. · Clinical Pharmacology & Therapeutics
Open access |
19 Oct 2021 |
24 |
| 25 |
Telehealth and Medicare Type 2 Diabetes Care Outcomes
Brigham Walker, Charles Stoecker, Yixue Shao et al. · Medical Care
Open access |
9 Mar 2023 |
23 |
| 26 |
Bridging e-business and added trust: keys to e-business growth
Hsunwei Hsiung, S. Scheurich, Frank E. Ferrante · IT Professional
|
2001 |
22 |
| 27 |
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals
George W. Sledge, Takayuki Yoshino, Joanne Xiu et al. · Nature Communications
Open access |
18 Mar 2025 |
21 |
| 28 |
COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid
Brigham Walker, Andrew C Anderson, Charles Stoecker et al. · Vaccine
Open access |
24 Dec 2021 |
21 |
| 29 |
Temozolomide analogs with improved brain/plasma ratios – Exploring the possibility of enhancing the therapeutic index of temozolomide
Roopa Rai et al. · Bioorganic & Medicinal Chemistry Letters
|
24 Aug 2016 |
19 |
| 30 |
Dual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury
Xi‐Chun May Lu, Deborah A. Shear, Philip B. Graham et al. · Journal of Neurotrauma
Open access |
20 Mar 2015 |
19 |
| 31 |
Real-World Treatment Patterns and Effectiveness Outcomes in Patients with Early-Stage Triple-Negative Breast Cancer
Amin Haiderali, Whitney Rhodes, Santosh Gautam et al. · Future Oncology
Open access |
6 Jul 2021 |
17 |
| 32 |
Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients
Marc D. Schwartz, Beth N. Peshkin, Claudine J. Isaacs et al. · Breast Cancer Research and Treatment
Open access |
2 Apr 2018 |
17 |
| 33 |
Design and synthesis of deuterated boceprevir analogs with enhanced pharmacokinetic properties
Adam J. Morgan, Sophia Nguyen, Vinita Uttamsingh et al. · Journal of Labelled Compounds and Radiopharmaceuticals
|
Jul 2011 |
17 |
| 34 |
Real-World Treatment Patterns and Outcomes in PD-L1-Positive Non-Small Cell Lung Cancer
Xinke Zhang, Richard W DeClue, Lisa Herms et al. · Immunotherapy
Open access |
4 Aug 2021 |
16 |
| 35 |
Advancing the genetic counseling profession through research: Identification of priorities by the National Society of Genetic Counselors research task force
Leigha Senter, Jehannine Austin, Meghan E. Carey et al. · Journal of Genetic Counseling
Open access |
23 Sep 2020 |
16 |
| 36 |
Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer
Whitney Rhodes, Richard W DeClue, Neil A. Accortt et al. · Future Oncology
Open access |
26 Oct 2021 |
15 |
| 37 |
Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer Before Starting Chemotherapy
Xin Yang Hu, Puneet Kaur Chehal, Cameron M. Kaplan et al. · JAMA Network Open
Open access |
Jun 2021 |
15 |
| 38 |
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resection
Howard West, Xiaohan Hu, Diana Romana Chirovsky et al. · Future Oncology
Open access |
23 May 2023 |
14 |
| 39 |
Quantitative analyses of CTP-499 and five major metabolites by core-structure analysis
Xiaonan Tang, Gary W. Bridson, Jing Ke et al. · Journal of Chromatography B
|
28 May 2014 |
14 |
| 40 |
Building an infrastructure to enable delivery of genomic medicine
Gillian W. Hooker · American Journal of Medical Genetics Part C Seminars in Medical Genetics
Open access |
7 Jan 2021 |
13 |
| 41 |
Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients
Mara Tynan, Beth N. Peshkin, Claudine J. Isaacs et al. · Breast Cancer Research and Treatment
Open access |
2020 |
13 |
| 42 |
Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)
Ran Jin, Adesuwa S. Ogbomo, Neil A. Accortt et al. · Therapeutic Advances in Medical Oncology
Open access |
2023 |
12 |
| 43 |
Real-World Outcomes in Metastatic HR+/HER2-, HER2+ and Triple Negative Breast Cancer after Start of First-Line Therapy
Richard W DeClue, Maxine D. Fisher, Kyna Gooden et al. · Future Oncology
Open access |
Apr 2023 |
12 |
| 44 |
Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Chemotherapy
Brittany Avin McKelvey et al. · JCO Clinical Cancer Informatics
Open access |
Aug 2024 |
11 |
| 45 |
Healthcare Resource Utilization and Cost Among Patients Treated for Early-Stage Triple-Negative Breast Cancer
Amin Haiderali, Whitney Rhodes, Santosh Gautam et al. · Future Oncology
Open access |
13 Jul 2021 |
11 |
| 46 |
Performance Testing for IP Services and Systems
Frank Huebner, Kathleen S. Meier-Hellstern, Paul Kevin Reeser · Lecture notes in computer science
Conference paper |
2001 |
11 |
| 47 |
Payer reimbursement practices and incentives for improving interpretation of germline genetic testing
Patricia A. Deverka, Janis Geary, Charles Mathews et al. · Journal of Law and the Biosciences
Open access |
Jul 2023 |
10 |
| 48 |
Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery
Rachel Shapira, Erin Turbitt, Lori Hamby Erby et al. · Familial Cancer
Open access |
5 Dec 2017 |
10 |
| 49 |
Emulations of oncology trials using real-world data: a systematic literature review
Jennifer R. Rider et al. · American Journal of Epidemiology
Review |
6 Sep 2024 |
9 |
| 50 |
Identification and Characterization of Oxymetazoline Glucuronidation in Human Liver Microsomes: Evidence for the Involvement of UGT1A9
Mukesh K. Mahajan, Vinita Uttamsingh, Liang-Shang L. Gan et al. · Journal of Pharmaceutical Sciences
Open access |
29 Jul 2010 |
9 |